{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:39:47Z","timestamp":1760315987835,"version":"build-2065373602"},"reference-count":54,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cell Biochemistry &amp;amp; Function"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec><jats:label\/><jats:p>Lixisenatide, a glucagon\u2010like peptide\u20101 (GLP\u20101) receptor agonist, is used in the treatment of type 2 diabetes mellitus (T2DM). It increases insulin (INS) secretion and can decrease INS resistance, improving metabolic disorders in this disease. However, its effects on metabolic disturbances in cancer\u2010bearing, which also exhibit decreased INS secretion and INS resistance, changes that may contribute to weight loss (cachexia), have not yet been evaluated. The purpose of this study was to investigate the lixisenatide treatment effects on mild cachexia and related metabolic abnormalities in Walker\u2010256 tumour\u2010bearing rats. Lixisenatide (50\u2009\u03bcg\u2009kg<jats:sup>\u22121<\/jats:sup>, SC) was administered once daily, for 6\u2009days, after inoculation of Walker\u2010256 tumour cells. Acute lixisenatide treatment did not improve hypoinsulinemia, INS secretion and INS resistance of tumour\u2010bearing rats. It also did not prevent the reduced glucose and increased triacylglycerol and lactate in the blood and nor the loss of retroperitoneal and epididymal fat of these animals. However, acute lixisenatide treatment accentuated the body mass loss of tumour\u2010bearing rats. Therefore, lixisenatide, unlike T2DM, does not improve hypoinsulinemia and INS resistance associated with cancer, evidencing that it does not have the same beneficial effects in these two diseases. In addition, lixisenatide aggravated weight loss of tumour\u2010bearing rats, suggesting that its use for treatment of T2DM patients with cancer should be avoided.<\/jats:p><\/jats:sec><jats:sec><jats:title>Significance of the study<\/jats:title><jats:p>Lixisenatide increases insulin secretion and appears to reduce insulin resistance in T2DM. However, lixisenatide treatment does not improve hypoinsulinemia and insulin resistance associated with cancer, as it does in T2DM, and aggravated weight loss, suggesting that its use for treatment of T2DM patients with cancer should be avoided.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cbf.3588","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T10:29:05Z","timestamp":1600943345000},"page":"335-343","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of lixisenatide treatment on mild cachexia and related metabolic abnormalities in Walker\u2010256 tumour\u2010bearing rats"],"prefix":"10.1002","volume":"39","author":[{"given":"D\u00e9bora L.","family":"Quintilhano","sequence":"first","affiliation":[{"name":"Department of Physiological Sciences State University of Londrina  Londrina Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele R.","family":"Miksza","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences State University of Londrina  Londrina Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana R.","family":"Biazi","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences State University of Londrina  Londrina Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabele G.","family":"Frasson\u2010Uemura","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences State University of Londrina  Londrina Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fernanda R.","family":"Graciano","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences State University of Londrina  Londrina Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e2nia L.","family":"Mazzuco","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine State University of Londrina  Londrina Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ngelo R.","family":"Carpinelli","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics University of S\u00e3o Paulo  S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1426-4069","authenticated-orcid":false,"given":"Helenir M.","family":"de Souza","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences State University of Londrina  Londrina Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0161-937X","authenticated-orcid":false,"given":"Gisele L.","family":"Bertolini","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences State University of Londrina  Londrina Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0009-4"},{"key":"e_1_2_9_3_1","first-page":"25","article-title":"Lixisenatide as add\u2010on therapy to basal insulin","volume":"8","author":"Brown DX","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2014.03.005"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.01.012"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12269"},{"key":"e_1_2_9_7_1","first-page":"503","article-title":"Lixisenatide, a novel GLP\u20101 receptor agonist for the treatment of type 2 diabetes mellitus","volume":"12","author":"Christensen M","year":"2009","journal-title":"IDrugs"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.140"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2010.05.008"},{"key":"e_1_2_9_10_1","first-page":"400","article-title":"The GLP\u20101 receptor agonist AVE0010 preserves beta cell function and insulin secretion after a 6 week treatment in male obese Zucker diabetic fatty rats\u2014an isolated perfused pancreas study","volume":"49","author":"Haschke G","year":"2006","journal-title":"Diabetologia"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/CE.S15525"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01560.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.838559"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S45379"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12253"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.2792"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.12.016"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2017-0171"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2014.02.005"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1139\/apnm-2013-0369"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3829"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2121-8"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.3"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00016.2008"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302002000400013"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.07.015"},{"key":"e_1_2_9_27_1","first-page":"1","article-title":"Akt activation by insulin treatment attenuates cachexia in Walker\u2010256 tumor\u2010bearing rats","author":"Fatima Silva F","year":"2020","journal-title":"J Cell Biochem"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000430326"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24784"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1004919"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.679"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/000456326900600108"},{"key":"e_1_2_9_33_1","first-page":"1205","volume-title":"Methods of Enzymatic Analysis","author":"Bergmeyer HU","year":"1974"},{"key":"e_1_2_9_34_1","first-page":"1464","volume-title":"Methods of Enzymatic Analysis","author":"Gutmann I","year":"1974"},{"key":"e_1_2_9_35_1","first-page":"1790","volume-title":"Methods of Enzymatic Analysis","author":"Gutmann I","year":"1974"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104130"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1996.271.3.C804"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1990.258.6.E1033"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-013-0163-9"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1770351"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e328042ba90"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000165803.47776.38"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.032482"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.1596"},{"key":"e_1_2_9_45_1","first-page":"193","article-title":"Insulin resistance was connected with the alterations of substrate utilization in patients with cancer","volume":"14","author":"Yoshikawa T","year":"1999","journal-title":"Cancer Lett"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300063200"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(13)71077-6"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2007.02.003"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2006.04.048"},{"key":"e_1_2_9_50_1","unstructured":"RebecaR BrachtL NoletoGR RochaMEM OliveiraMBM.L\u2010Glutamine and L\u2010Arginine Utilization by Walker 256 Cells. XXXV Reuni\u00e3o Anual SBBq \u00c1guas de Lind\u00f3ia Anal da Sociedade Brasileira de Bioqu\u00edmica e Biologia Molecular;2006."},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(92)90134-O"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1677\/jme.1.01747"},{"key":"e_1_2_9_53_1","first-page":"1133","article-title":"Effect of GLP\u20101 on D\u2010glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects","volume":"17","author":"Sancho V","year":"2006","journal-title":"Int J Mol Med"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2013.06.003"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.01.003"}],"container-title":["Cell Biochemistry and Function"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbf.3588","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cbf.3588","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbf.3588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:36:44Z","timestamp":1760276204000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/cbf.3588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1002\/cbf.3588"],"URL":"https:\/\/doi.org\/10.1002\/cbf.3588","archive":["Portico"],"relation":{},"ISSN":["0263-6484","1099-0844"],"issn-type":[{"type":"print","value":"0263-6484"},{"type":"electronic","value":"1099-0844"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"2020-04-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}